Sign in
HOTH Stock Price, Chart, Stats & News
Hoth Therapeutics, Inc.
Save
Hoth Therapeutics, Inc. (HOTH) does not currently pay a dividend.
10.62M
Market cap
–
Current P/E
–
Forward P/E
HOTH chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -131.58% |
ROE | -133.69% |
D/E | 0.00x |
Interest coverage ratio | – |
HOTH valuation
P/E | – |
P/S | – |
P/B | 1.35x |
P/CF | -1.13x |
P/FCF | -1.09x |
P/OCF | -1.13x |
PEG | -1.07x |
EV multiple | -2.94x |
About
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema.
Similar securities
Based on sector and market capitalization
Report issue